Marks calls for new gene therapy development paradigm
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaRegulatory Intelligence/PolicyResearch, Design and Development